- Home
- COLL vs CLOV Comparison
COLL vs CLOV Comparison
Compare COLL & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- CLOV
- Stock Information
- Founded
- COLL 2002
- CLOV 2014
- Country
- COLL United States
- CLOV United States
- Employees
- COLL N/A
- CLOV N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- CLOV Medical Specialities
- Sector
- COLL Health Care
- CLOV Health Care
- Exchange
- COLL Nasdaq
- CLOV Nasdaq
- Market Cap
- COLL 1.1B
- CLOV 1.3B
- IPO Year
- COLL 2015
- CLOV N/A
- Fundamental
- Price
- COLL $45.49
- CLOV $2.35
- Analyst Decision
- COLL Strong Buy
- CLOV Strong Buy
- Analyst Count
- COLL 5
- CLOV 3
- Target Price
- COLL $45.40
- CLOV $4.23
- AVG Volume (30 Days)
- COLL 520.4K
- CLOV 11.2M
- Earning Date
- COLL 11-06-2025
- CLOV 11-04-2025
- Dividend Yield
- COLL N/A
- CLOV N/A
- EPS Growth
- COLL N/A
- CLOV N/A
- EPS
- COLL 1.63
- CLOV N/A
- Revenue
- COLL $757,067,000.00
- CLOV $1,773,564,000.00
- Revenue This Year
- COLL $21.41
- CLOV $40.52
- Revenue Next Year
- COLL $3.28
- CLOV $31.46
- P/E Ratio
- COLL $28.29
- CLOV N/A
- Revenue Growth
- COLL 26.34
- CLOV 32.15
- 52 Week Low
- COLL $23.23
- CLOV $2.12
- 52 Week High
- COLL $48.18
- CLOV $4.87
- Technical
- Relative Strength Index (RSI)
- COLL 74.50
- CLOV 33.98
- Support Level
- COLL $35.26
- CLOV $2.48
- Resistance Level
- COLL $48.18
- CLOV $3.72
- Average True Range (ATR)
- COLL 1.74
- CLOV 0.19
- MACD
- COLL 0.93
- CLOV -0.11
- Stochastic Oscillator
- COLL 80.20
- CLOV 2.08
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.